Showing 141 - 160 results of 64,576 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((non decrease) OR (nn decrease)) ))', query time: 0.85s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  10. 150
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157

    Decreased MBP levels in the brain in <i>Large</i><sup><i>myd/myd</i></sup> mice. by Shigefumi Morioka (8893511)

    Published 2020
    “…<b>B,</b> Whole-brain lysates of P7 control and <i>Large</i><sup><i>myd/myd</i></sup> mice (<i>n</i> = 5) were obtained for MBP immunoblotting. Decreased expression levels of MBP were observed in <i>Large</i><sup><i>myd/myd</i></sup> mice compared with those in control mice. …”
  18. 158
  19. 159
  20. 160